Target and Its Patented Drug(s)
| Target General Information | Top | ||||
|---|---|---|---|---|---|
| Target ID | T11487 | Target Info | |||
| Target Name | Acetoacetyl-CoA thiolase (ACAT1) | ||||
| Synonyms | T2; MAT; Acetyl-CoA acetyltransferase, mitochondrial | ||||
| Target Type | Clinical trial Target | ||||
| Gene Name | ACAT1 | ||||
| Biochemical Class | Acyltransferase | ||||
| UniProt ID | |||||
| Patent(s) and the Corresponding Patented Drug(s) | Top | ||||
|---|---|---|---|---|---|
| World Intellectual Property Organization (WIPO) | |||||
| Patent ID | WO2011161964 | ||||
| Title | Agent for Improving Insulin Resistance with Acat Inhibitor As Active Component. | ||||
| Abstract | In the present invention, a chemical compound having an insulin-resistance improving effect or a blood-sugar reducing effect is found, and a drug for the prevention and treatment of diseases caused by high blood sugar, such as diabetes, is provided. The present invention relates to a prophylactic or therapeutic agent for diabetes, and insulin resistance in particular, having an ACAT inhibitor as an active component thereof. | ||||
| Applicant(s) | Kowa Company, Ltd | ||||
| Representative Drug(s) | D04TSP | Drug Info | N.A. | [1] | |
| References | Top | ||||
|---|---|---|---|---|---|
| REF 1 | Acyltransferase inhibitors: a patent review (2010-present).Expert Opin Ther Pat. 2015 Feb;25(2):145-58. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.